Core Viewpoint - The successful implementation of the world's first remote robotic retinal injection surgery in China marks a significant breakthrough in the field of remote high-precision ophthalmic surgery, addressing the uneven distribution of quality medical resources in the country [1][2]. Group 1: Surgical Innovation - The surgery utilized a domestically developed 5G ophthalmic surgical robot, enabling real-time connection between the control center in Guangzhou and the surgical site in Urumqi, achieving precise operations at the micron level [1][2]. - The entire remote operation took less than 7 minutes, demonstrating stable network performance, clear imaging, and responsive robotic control during the injection process [1][2]. Group 2: Medical Resource Challenges - China has the highest number of visually impaired and blind patients globally, with many facing difficulties accessing expert care due to a lack of medical resources in certain regions [2][3]. - The remote surgical platform aims to solve the issue of "seeing the disease but not the expert," particularly in under-resourced areas [2]. Group 3: Research and Development - The team led by Professor Lin Haotian has been working on the remote ophthalmic surgical robot platform for over two years, collaborating with various institutions to achieve this milestone [2][3]. - The team has previously conducted successful animal experiments and published their findings in the high-impact journal Advanced Science [2]. Group 4: Future Implications - The introduction of ophthalmic surgical robots is expected to enhance the quality of eye care for more patients and revolutionize the training of medical professionals, contributing to a more balanced regional healthcare level [4].